Enantiomer-specific actions of perhexiline

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1075767

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Many heart diseases are associated with impairment of energetics of the heart. Improving the heart's energetics can lead to improved survival and long-term outcomes. Perhexiline is a heart medication that works by improving the way the heart uses energy. Although effective, it is associated with long-term toxicities. Better understanding of this medication may lead to less adverse effects and also provide a basis for further investigation of drug development in the future.

Funded Activity Details

Start Date: 01-01-2014

End Date: 01-01-2015

Funding Scheme: Postgraduate Scholarships

Funding Amount: $62,155.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cardiology (incl. Cardiovascular Diseases)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

cardiology | energy metabolism | fatty acid oxidation | glucose metabolism | inflammation | oxidative stress

Related Links